Many of the genes identified in our study have not been demonstrated to be associated with colorectal cancer risk, such as NBN, ATR, or RAD50. Notably, the majority of these patients lacked clinical phenotypes of corresponding hereditary syndromes. This evidence concerns the gene RAD50 and colorectal cancer.